PAMMOTH

Photoacoustic Mammoscopy for evaluating screening-detected lesions in the breast

Project duration: 01.01. 2017 - 30.06. 2021     terminated

 

PAMMOTH was supported by the European Commision's Horizon 2020 ICT 2016-2017 programme under the grant agreement No 732411
and is an initiative of the Photonics Public Private Partnership.

 

Coordinator

University of Twente
The Biomedical Photonic Imaging (BMPI) group
Prof. Dr. Srirang Manohar

Partners

PA Imaging R&D B.V
Stichting Medisch Spectrum Twente
University College London
University of Bern
Brno University of Technology
Imasonic SAS
EKSPLA

tp21 GmbH

 

Objectives

 

PAMMOTH’s objective is to develop, validate and begin exploitation of a dedicated breast imaging device for a significant impact in breast cancer diagnosis. The proposed device combines non-invasive 3D photoacoustic imaging and ultrasound imaging. The device will provide near real-time, full-breast, multimodal images to the radiologist. From the ultrasound mode, the radiologist will visualize anatomical features and extent of tumors, and from multiwavelength photoacoustics, she will see tumor vascularity. Quantitative spectroscopic photoacoustic images will be extracted off-line, providing the radiologist information relating to tumor physiology and function such as angiogenesis and hypoxia.

The choice of the relevant biological targets, and of the functionalities and technical principles applied in the PAMMOTH imager, will enable sensitive, accurate and quantitative measurements of these targets. This will provide relevant information to the radiologist to make accurate diagnosis with high specificity.

 

PAMMOTH video

 

 

 

Final Project Executive Summary and Results    

 

©  Images under copyright of the PAMMOTH consortium.